<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01890369</url>
  </required_header>
  <id_info>
    <org_study_id>B13122012 GEM BMS</org_study_id>
    <nct_id>NCT01890369</nct_id>
  </id_info>
  <brief_title>Modulation of Muscle Protein Metabolism by Essential Amino Acids</brief_title>
  <acronym>Aj1B</acronym>
  <official_title>Modulation of Muscle Protein Metabolism by Essential Amino Acids</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Nottingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ajinomoto Co., Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Nottingham</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators plan to explore the ability of amino acids, the building blocks of proteins
      in our bodies and in the food we eat, to stimulate muscles to grow and stay strong. The
      investigators will investigate how rapidly after one meal the human body is ready to make use
      of a second meal and look at the molecular mechanisms underlying this. The investigators will
      look at these phenomena in older men as this group is known to be subject to a gradual loss
      of muscle mass and strength.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Muscles can stay very constant in size for much of adult life yet dramatic wasting is seen in
      advanced age and ill health. A better understanding of how muscles regulate their size will
      help design treatments to slow wasting in disease and to promote active aging. We plan to
      study a group of older men, ~70yrs, the age at which muscle bulk starts to decrease, to
      observe how the muscles respond to feeding. We will provide a drink that contains the
      digested products of proteins from which muscles are built. Taking blood samples and some
      tiny biopsies of muscle (done under local anaesthesia) will allow us to measure muscle
      turnover and we will be able to measure for how long after a meal muscles actively take in
      nutrients before becoming &quot;full&quot;. We will also measure how long the muscle remains &quot;full&quot;
      before it returns to a state where it can again be stimulated to take in nutrients. We will
      also explore if leucine, one of the component parts of protein (especially in meat and dairy
      products) and a food widely used supplement, can promote the early re-stimulation of muscle
      by eating.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Myofibrillar Fractional Synthetic Rate</measure>
    <time_frame>6-10hrs</time_frame>
    <description>Assessed by gas-chromatography-combustion-mass spectrometry, using incorporation of a stable isotope tracer (13-C-6 Phe)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Leg blood flow</measure>
    <time_frame>6-10hrs</time_frame>
    <description>Common femoral bulk flow (Doppler USS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mTORC1 and AKT phosphorylation</measure>
    <time_frame>6-10hrs</time_frame>
    <description>Western Immunoblotting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle Protein Breakdown</measure>
    <time_frame>6-10hrs</time_frame>
    <description>By Arteriovenous limb balance</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Old Age</condition>
  <arm_group>
    <arm_group_label>Early leucine refeed</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>15g Mixed Essential Amino Acids. 90 min delay. 3g Leucine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Early EAA refeed</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>15g Mixed Essential Amino Acids. 90 min delay. 15g Mixed Essential Amino Acid REFEED</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mid latency EAA refeed</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>15g Mixed Essential Amino Acids. 150 min delay. 15g Mixed Essential Amino Acid REFEED</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Late latency EAA refeed</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>15g Mixed Essential Amino Acids. 210 min delay. 15g Mixed Essential Amino Acid REFEED</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>15g Mixed Essential Amino Acids</intervention_name>
    <description>Dissolved in 250ml water.</description>
    <arm_group_label>Early leucine refeed</arm_group_label>
    <arm_group_label>Early EAA refeed</arm_group_label>
    <arm_group_label>Mid latency EAA refeed</arm_group_label>
    <arm_group_label>Late latency EAA refeed</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>3g Leucine</intervention_name>
    <description>Dissolved in 250ml water.</description>
    <arm_group_label>Early leucine refeed</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>15g Mixed Essential Amino Acid REFEED</intervention_name>
    <description>Dissolved in 250ml water.</description>
    <arm_group_label>Early EAA refeed</arm_group_label>
    <arm_group_label>Mid latency EAA refeed</arm_group_label>
    <arm_group_label>Late latency EAA refeed</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male

          -  65-75yrs

          -  BMI 18-28

        Exclusion Criteria:

          -  Type 2 Diabetes mellitus

          -  Neurological Disease

          -  Significant cardiac, hepatic or renal disease

          -  Active malignancy

          -  Medication inc. Corticosteroids, NSAID use, Beta adrenoblockers.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philip J Atherton, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Nottingham</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>School of Graduate Entry Medicine</name>
      <address>
        <city>Derby</city>
        <zip>DE22 3DT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William K Mitchell, MA,MB,BChir</last_name>
      <phone>(+44)1332 724681</phone>
      <email>kylemitchell@doctors.net.uk</email>
    </contact>
    <investigator>
      <last_name>William K Mitchell, MA MB BChir</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philip J Atherton, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 26, 2013</study_first_submitted>
  <study_first_submitted_qc>June 28, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 1, 2013</study_first_posted>
  <last_update_submitted>January 16, 2014</last_update_submitted>
  <last_update_submitted_qc>January 16, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 17, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Old Age</keyword>
  <keyword>Sarcopenia</keyword>
  <keyword>Amino Acid</keyword>
  <keyword>Muscle</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

